Locally Advanced Solid Tumors Clinical Trials

10 clinical trials for Locally Advanced Solid Tumors across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements — RECRUITING · PHASE1
• A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations — RECRUITING · PHASE1
• A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. — TERMINATED · PHASE1
• Imaging of Advanced Tumours Using [131]I-IAZA — WITHDRAWN · PHASE1
• A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors — OTHER · PHASE1
• Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. — COMPLETED · PHASE1
• Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors — COMPLETED · PHASE1

Refine this search